| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Jan 25 | EYPT EyePoint Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 8.26 | 40,000 | 330.40 k | 40,000 |
| 20 Aug 24 | EYPT EyePoint Pharmaceuticals | Common Stock | Buy | Acquire P | No | No | 7.79 | 2,567 | 20.00 k | 9,967 |
| 1 May 24 | AKTX Akari Therapeutics | Ordinary Shares, par value $0.0001 per share | Grant | Acquire A | No | No | 0 | 158,473,915 | 0.00 | 158,473,915 |
| 5 Jan 24 | EYPT EyePoint Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 20.4 | 25,014 | 510.29 k | 25,014 |
